D.E. Shaw increases ownership of Endo to 9.6%

By Lisa Kerner

Charlotte, N.C., Dec. 21 - Affiliates of D.E. Shaw Composite International Fund increased their ownership of Endo Pharmaceuticals Holdings Inc. to 9.6% from 8.4%, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors bought a total of 1,650,545 shares of Endo stock between Nov. 21 and Dec. 19 priced from $26.05 to $28.00 per share.

D.E. Shaw now owns 12,938,532 shares of Endo.

Endo is a pharmaceutical company based in Chadds Ford, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.